Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Stellate Ganglion Block (SGB) on Vasomotor Symptoms in Women Receiving Anti-Estrogen Therapy for Breast Cancer

NCT02513329 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT02513329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02513329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Stellate Ganglion Block (SGB) on Vasomotor Symptoms in Women Receiving Anti-Estrogen Therapy for Breast Cancer
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2015
Completion date
January 31, 2020
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hot flashes, hot flushes